-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Congo Red Stain Bone Marrow Screening for AL Amyloidosis

Program: Special-Interest Sessions
Session: ASH Clinical Practice Guidelines on Amyloidosis
Hematology Disease Topics & Pathways:
Acute Myeloid Malignancies, AML, Clinical Practice (Health Services and Quality), Diseases, Myeloid Malignancies
Sunday, December 8, 2024, 4:30 PM-6:00 PM

Naresh Bumma, MD

The Ohio State University, Columbus, OH

Disclosures: Bumma: Amgen: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Janssen: Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; sanofi: Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau.

See more of: ASH Clinical Practice Guidelines on Amyloidosis
See more of: Special-Interest Sessions
<< Previous Presentation | Next Presentation